- Home
- OST vs NEUP Comparison
OST vs NEUP Comparison
Compare OST & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- NEUP
- Stock Information
- Founded
- OST 2010
- NEUP 1996
- Country
- OST China
- NEUP United States
- Employees
- OST N/A
- NEUP N/A
- Industry
- OST Industrial Machinery/Components
- NEUP
- Sector
- OST Technology
- NEUP
- Exchange
- OST Nasdaq
- NEUP Nasdaq
- Market Cap
- OST 15.7M
- NEUP 12.7M
- IPO Year
- OST 2022
- NEUP N/A
- Fundamental
- Price
- OST $1.66
- NEUP $11.89
- Analyst Decision
- OST
- NEUP Strong Buy
- Analyst Count
- OST 0
- NEUP 1
- Target Price
- OST N/A
- NEUP $21.00
- AVG Volume (30 Days)
- OST 185.8K
- NEUP 67.0K
- Earning Date
- OST 09-19-2025
- NEUP 08-28-2025
- Dividend Yield
- OST N/A
- NEUP N/A
- EPS Growth
- OST N/A
- NEUP N/A
- EPS
- OST N/A
- NEUP 0.00
- Revenue
- OST $38,333,251.00
- NEUP $15,662,715.00
- Revenue This Year
- OST N/A
- NEUP N/A
- Revenue Next Year
- OST N/A
- NEUP N/A
- P/E Ratio
- OST N/A
- NEUP $3.84
- Revenue Growth
- OST 0.34
- NEUP N/A
- 52 Week Low
- OST $1.35
- NEUP $2.90
- 52 Week High
- OST $235.00
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- OST 26.79
- NEUP 67.40
- Support Level
- OST $1.50
- NEUP $6.82
- Resistance Level
- OST $2.07
- NEUP $13.25
- Average True Range (ATR)
- OST 0.23
- NEUP 1.32
- MACD
- OST 1.49
- NEUP 0.44
- Stochastic Oscillator
- OST 19.14
- NEUP 77.78
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.